Related Experiment Video
Updated: Apr 25, 2026

Fluorescence Assays for the Study of Mycobacterium tuberculosis Interaction with the Immune Receptor SLAMF1
Published on: February 28, 2025
Microarray analysis of Mycobacterium tuberculosis-infected monocytes reveals IL26 as a new candidate gene for
José M Guerra-Laso1, Sara Raposo-García, Silvia García-García
1Servicios de Medicina Interna, Complejo Asistencial Universitario de León (CAULE), León, Spain.
Abstract:
Differences in the activity of monocytes/macrophages, important target cells of Mycobacterium tuberculosis, might influence tuberculosis progression. With the purpose of identifying candidate genes for tuberculosis susceptibility we infected monocytes from both healthy elderly individuals (a tuberculosis susceptibility group) and elderly tuberculosis patients with M. tuberculosis, and performed a microarray experiment. We detected 78 differentially expressed transcripts and confirmed these results by quantitative PCR of selected genes. We found that monocytes from tuberculosis patients showed similar expression patterns for these genes, regardless of whether they were obtained from younger or older patients. Only one of the detected genes corresponded to a cytokine: IL26, a member of the interleukin-10 (IL-10) cytokine family which we found to be down-regulated in infected monocytes from tuberculosis patients. Non-infected monocytes secreted IL-26 constitutively but they reacted strongly to M. tuberculosis infection by decreasing IL-26 production. Furthermore, IL-26 serum concentrations appeared to be lower in the tuberculosis patients. When whole blood was infected, IL-26 inhibited the observed pathogen-killing capability. Although lymphocytes expressed IL26R, the receptor mRNA was not detected in either monocytes or neutrophils, suggesting that the inhibition of anti-mycobacterial activity may be mediated by lymphocytes. Additionally, IL-2 concentrations in infected blood were lower in the presence of IL-26. The negative influence of IL-26 on the anti-mycobacterial activity and its constitutive presence in both serum and monocyte supernatants prompt us to propose IL26 as a candidate gene for tuberculosis susceptibility.
Insights
Interleukin-26 (IL-26) is down-regulated in tuberculosis patients, reducing the body's ability to fight Mycobacterium tuberculosis. Lower IL-26 levels may indicate increased tuberculosis susceptibility.
Area of Science:
- Immunology
- Genetics
- Infectious Diseases
Background:
- Monocyte/macrophage activity is crucial in Mycobacterium tuberculosis infection.
- Elderly individuals are a known tuberculosis susceptibility group.
Purpose of the Study:
- Identify candidate genes associated with tuberculosis susceptibility.
- Investigate the role of interleukin-26 (IL-26) in tuberculosis.
Main Methods:
- Infection of monocytes from healthy elderly individuals and tuberculosis patients with M. tuberculosis.
- Microarray analysis to detect differentially expressed transcripts.
- Quantitative PCR for gene expression validation.
- Measurement of IL-26 serum concentrations and its effect on M. tuberculosis killing capability in whole blood.
Main Results:
- 78 differentially expressed transcripts were identified, with IL-26 being significantly down-regulated in infected monocytes from tuberculosis patients.
- IL-26 production decreased upon M. tuberculosis infection.
- Lower IL-26 serum concentrations were observed in tuberculosis patients.
- IL-26 inhibited pathogen-killing capability in whole blood, potentially mediated by lymphocytes.
Conclusions:
- IL-26 may play a role in modulating the anti-mycobacterial response.
- Down-regulation of IL-26 is associated with tuberculosis.
- IL26 is proposed as a candidate gene for tuberculosis susceptibility.

